CeloNova
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
N/A | $20.8m | Late VC | |
N/A | - | ||
Total Funding | €18.9m |
Recent News about CeloNova
EditAlta Biomaterials specializes in developing proprietary coating technologies for medical devices, aimed at enhancing biocompatibility, drug delivery, and providing anti-inflammatory, thromboresistant, and pro-healing properties. The company partners with original equipment manufacturers (OEMs) in the medical device industry to co-develop and optimize implant interactions within the body. Operating primarily in the US and European markets, Alta Biomaterials has a strong track record of product development and commercialization. The business model revolves around forming strategic partnerships with medical device manufacturers, leveraging their expertise in PzF applications and other advanced materials to create innovative solutions that improve patient outcomes. Revenue is generated through these partnerships and the commercialization of their proprietary technologies.
Keywords: medical device coatings, biocompatibility, drug delivery, anti-inflammatory, thromboresistant, pro-healing, OEM partnerships, PzF applications, US market, European market.